Treatment with the TROP2 ADC sac-TMT led to a 70% objective response rate and progression-free survival was “significantly ...

Radiation therapy is a treatment that uses high-energy rays, like X-rays, gamma rays or protons, to target and destroy cancer cells. It works by damaging the DNA of cancer cells, preventing them from ...

Sichuan Kelun-Biotech Biopharmaceutical said on Thursday its experimental treatment combined with partner Merck's Keytruda ...

Sponsor: Boom Broadcast & Media Relations on behalf of LCFAmerica Lung cancer treatment is undergoing a quiet but meaningful ...

Immunotherapy is a cancer treatment that harnesses the body’s immune system to fight cancer. It helps the immune system recognize and attack cancer cells, which can sometimes be hidden from the body’s ...

A new drug combo recently approved by the Food & Drug Administration can halt lung cancer in its treacherous tracks — for over 40% longer than previously possible, a wide-ranging trial funded by ...

New drugs have made America’s deadliest cancer more treatable than ever. So why aren’t they reaching patients?

A team of researchers from the Keck School of Medicine of USC, the USC Alfred E. Mann School of Pharmacy and Pharmaceutical ...

Chinese biopharma company Kelun-Biotech announced on Thursday that an antibody drug conjugate it is developing with Merck (MRK), with Keytruda, outperformed the U.S. drugmaker’s anti-PD-1 therapy in a ...

“Me-too” strategies in lung cancer do not always translate to lower treatment costs and improved treatment access. Low-dose targeted therapies and immunotherapies can be considered to improve acces ...

This segment is brought to you by LCFAmerica. A new treatment option, SubQ, is helping some lung cancer patients spend less ...